<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0012126'>Gastric cancer</z:hpo> is one of the most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> of the gastrointestinal system, and its overall five-year survival rate is still 15 % to 20 %, as it can mostly be diagnosed at an advanced stage </plain></SENT>
<SENT sid="1" pm="."><plain>On the other hand, although <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has a rather good prognosis, mortality is one half that of the incidence.As <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> is believed to involve reactive radicals that cause DNA adduct formation, impaired repair activity, and weakened <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppression, it would help to understand the role of the polymorphisms of nucleotide excision repair enzyme XRCC1 and of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor gene p53 in gastric and <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Our study included 94 <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> patients, 96 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients, and 108 cancer-free individuals as control with the aim to see if there was an association between XRCC1 Arg399Gln and p53 Arg72Pro polymorphisms and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> susceptibility </plain></SENT>
<SENT sid="3" pm="."><plain>DNA was extracted from peripheral blood cells and genotypes were determined using the polymerase chain reaction-restriction fragment length polymorphism </plain></SENT>
<SENT sid="4" pm="."><plain>Polymorphism p53 Arg72Pro was not associated with either gastric or colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp>, while XRCC1 Arg399Gln was not associated with the increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>However, XRCC1 homozygous Gln allele at codon 399 was associated with 2.54 times higher risk of <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> </plain></SENT>
</text></document>